ID: ALA1762072
Chembl Id: CHEMBL1762072
PubChem CID: 10518587
Max Phase: Preclinical
Molecular Formula: C15H16N2O5
Molecular Weight: 304.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOC(=O)CN1C(=O)C(=O)N(Cc2ccccc2C)C1=O
Standard InChI: InChI=1S/C15H16N2O5/c1-3-22-12(18)9-17-14(20)13(19)16(15(17)21)8-11-7-5-4-6-10(11)2/h4-7H,3,8-9H2,1-2H3
Standard InChI Key: GSIJQHRBRXRQHM-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 304.30 | Molecular Weight (Monoisotopic): 304.1059 | AlogP: 0.85 | #Rotatable Bonds: 5 |
| Polar Surface Area: 83.99 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
| #RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 1.46 | CX LogD: 1.46 |
| Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.46 | Np Likeness Score: -1.49 |
| 1. Rajabi M, Mansell D, Freeman S, Bryce RA.. (2011) Structure-activity relationship of 2,4,5-trioxoimidazolidines as inhibitors of thymidine phosphorylase., 46 (4): [PMID:21324566] [10.1016/j.ejmech.2011.01.035] |
Source(1):
